Navigation Links
Landmark study of more than 27,000 women shows favorable results of Roche's CINtec PLUS cytology test
Date:11/4/2013

ec PLUS test with HPV DNA testing would make a lot of sense."

More than 500,000 new cases of cervical cancer are diagnosed each year worldwide.2 Disappointingly, the average five-year survival rate of patients is only around 50%.2 HPV infections are common and cause virtually all cervical cancer.2  However, only those women with persistent HPV infections and who have developed high-grade precancerous cervical disease should be treated. The CINtec PLUS cytology test was developed to help identify those HPV infections that may lead to cancer and distinguish them from those that will not.

The authors (Safaeian and Sherman) of an editorial published along with the PALMS study results write that dual biomarker screening could have a role in primary screening, especially in younger women. They also conclude that the dual assay could serve as a triage for positive HPV tests and could dramatically decrease patient referrals to colposcopy and other invasive and costly procedures unnecessarily.

"The results demonstrated in the PALMS trial reinforces the medical value Roche brings to cervical cancer screening.  We are committed to improving patient outcomes by providing differentiated diagnostic tools for doctors and laboratories," says Mara G. Aspinall, President, Ventana Medical Systems, Inc.  "We are pleased to announce that a fully automated version of the CINtec® PLUS cytology test will be launching later this year and will join the cobas® HPV test and the CINtec® Histology test to complete our portfolio of cervical cancer screening products."

*The CINtec® PLUS cytology test is not available in all geographies and/or may not be approved for all uses discussed in this press release.

1JNCI – The Journal of the National Cancer Institute (Ikenberg et al. Screening for Cervical Cancer Precursor
'/>"/>

SOURCE Ventana Medical Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Survey of Participants from Landmark GRACE Trial Provides Patients Perspectives from an HIV Clinical Study
2. Behind the Landmark Weeks Case
3. Millennium Laboratories Announces Landmark Pharmacogenetics Clinical Outcomes Study
4. Fuse Science Announces Landmark Licensing Agreement with Industry Leader Macular Health
5. SurgiCount Medical Achieves Landmark Product Usage And Customer Milestones
6. PRA Participates in Landmark Alzheimers Prevention Clinical Trial
7. President Obama Signs Landmark Accessible Prescription Drug Label Bill
8. Mylan Applauds Signing of Landmark "Food and Drug Administration Safety and Innovation Act"
9. Landmark Sleep Apnea, Heart Failure Study Recruits 1,000th Participant
10. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
11. Sangamo BioSciences Presents Clinical Data From SB-728-T HIV Study Demonstrating Long-Term Immune Reconstitution and Reduction in the HIV DNA Reservoir In Subjects with Long-Term Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 1, 2014  Dyadic International, Inc. ("Dyadic") (OTCQX: ... proprietary technology used to develop and produce enzymes ... biopharmaceuticals, and industrial enzymes industries, today announced the ... Bioenergy for commercial scale production of Abengoa,s proprietary ... developed under Abengoa,s license agreement with Dyadic. ...
(Date:10/1/2014)... NEW YORK , October 1, 2014 ... and service provider for the medical industries, announced today the expansion ... New York City . genae Americas was incorporated ... is strategically centered in one of the highest concentrations of medical ... Philippe Kassab , President at genae Americas. "The expansion of genae ...
(Date:10/1/2014)... Oct. 1, 2014  Varian Medical Systems (NYSE: ... results for the fourth quarter of fiscal year 2014 ... 22, 2014.  The news release will be followed by ... p.m. PT.  The news release and a link to ... company website at: www.varian.com/investor .  To access the ...
Breaking Medicine Technology:Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 2Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 3genae Opens Offices in New York City 2Varian Medical Systems Schedules Fourth Quarter FY2014 News Release and Conference Call 2
... Sept. 9 Luminex Corporation (Nasdaq: LMNX ... Global Life Sciences Conference to be held September 20 ... (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) (Logo: ... Patrick J. Balthrop, president and chief executive officer, will ...
... NEW YORK, Sept. 9 Reportlinker.com announces that a new ... US Enzymes Market http://www.reportlinker.com/p091893/US-Enzymes-Market.html ... 2014 Demand for enzymes in the US is forecast to ... 2014. Solid industry growth in recent years has been founded ...
Cached Medicine Technology:Luminex Corporation to Present at UBS Global Life Sciences Conference 2Reportlinker Adds US Enzymes Market 2Reportlinker Adds US Enzymes Market 3Reportlinker Adds US Enzymes Market 4Reportlinker Adds US Enzymes Market 5Reportlinker Adds US Enzymes Market 6Reportlinker Adds US Enzymes Market 7Reportlinker Adds US Enzymes Market 8
(Date:10/1/2014)... Farmington Company today announced it has ... visual identity helping brokers, consultants and companies to ... create greater benefit communication synergies. They unveiled a ... customers to better leverage Farmington Company’s industry-tested experience ... the rebrand is the refreshed tagline: For the ...
(Date:10/1/2014)... A new genetic finding from Duke Medicine suggests that ... depression might also be hard-wired to gain weight when ... disease. , An estimated 13 percent of people, all ... and knowing this could help them reduce heart disease ... and stress management. , "Genetic susceptibility, psychosocial stress and ...
(Date:10/1/2014)... Between 23 million and 50 million ... to figures from the National Institutes of Health (NIH) ... many of them have something else in common: They ... disease. Gluten Free Therapeutics, makers of CeliVites ... disease by publishing a series of blog posts aimed ...
(Date:10/1/2014)... City, NJ (PRWEB) October 01, 2014 Diet ... with their intentions to lose weight and their dieting attempts ... unhealthy, fatty foods. Including hormone diet treatments into ... only allows patients to see fast and effective weight loss ... and begin forming healthy habits to maintain their weight for ...
(Date:10/1/2014)... October 01, 2014 Anti Aging Clinic ... skin rejuvenating destination of choice, is announcing a discounted ... through to December. , “We’re doing this because we ... to our top skin clinic in Toronto,” says Dr. ... so much at Anti Aging Clinic, including laser facials, ...
Breaking Medicine News(10 mins):Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4Health News:Anti Aging Clinic, the GTA’s Premier Provider of Anti Aging Treatments, Announces Deal on Units of Botox 2
... -- Deadly and difficult to treat, liver cancer has long ... and prevent recurrence. But Mayo Clinic Cancer Center, in collaboration ... of Hepatology that the protein sulfatase 2 (SULF2) may provide ... new therapies. , Mayo Clinic Cancer Center leads the field ...
... Methodist Healthcare -- Memphis,Hospitals ("Methodist") announced today that ... designated maturities of the,Bonds. The tender offer was extended ... April 9, 2008 at 5:00 pm, New York City ... be terminated is applicable to,the following: for the Series ...
... CITY, Calif., April 10 Abaxis, Inc.,(Nasdaq: ... analysis systems, announced today that Clint Severson, Chief,Executive ... 37th,Annual Institutional Unconference on Tuesday, April 15, 2008 ... Atlanta, Georgia., Interested investors are invited to ...
... ANN ARBOR, Mich.---Female penguins mate with males who bring ... gain access to the most productive flowers guarded by ... affluent college students who don,t need resources will still ... Kruger, research scientist at the University of Michigan School ...
... trials could start in several years, study says , , THURSDAY, ... the formation of scar tissue at the site of a ... has been developed by researchers at Northwestern University in Chicago. ... to regrow after a spinal injury, but they,re blocked by ...
... inhibitors exhibit cancer-killing activities in cultured cells. While ... in clinical trials, just how they execute their ... of recent papers, Vanderbilt-Ingram Cancer Center investigators provide ... damage cancer cells and offer clues about possible ...
Cached Medicine News:Health News:Mayo Clinic identifies treatment target for liver cancer recurrence and survival 2Health News:Methodist Healthcare - Memphis Hospitals Announces Termination of Tender Offers 2Health News:Abaxis to Present at the SunTrust Robinson Humphrey's 37th Annual Institutional Unconference 2Health News:Just like penguins and other primates, people trade sex for resources 2Health News:Gel Enables Severed Spinal Cord Fibers to Regrow 2Health News:The good and bad side of anti-cancer compounds 2Health News:The good and bad side of anti-cancer compounds 3
... Strep A Test is a color immunochromatographic ... uses antibody labeled color particles coated at ... DLT allows greater sensitivity than the conventional ... the test procedure, a throat swab is ...
... The IntraLase FS laser introduces new high ... Surgeons now have the opportunity to offer ... to a microkeratome for creating the corneal ... FS laser and proprietary IntraLASIK software, surgeons ...
... Teco Diagnostics manufactures fine urine ... our urine chemistry reagent strips from ... to offer more economical prices compared ... the quality. Teco Diagnostics urine reagent ...
... term complications associated with diabetes continue to ... and quality of life of patients, in ... complications are known to be associated with ... that the level of haemoglobin A1c (HbA1c) ...
Medicine Products: